摘要
目的:构建HBV孕产妇核苷类抗病毒治疗健康教育路径,使健康教育内容完整、流程规范。方法在文献回顾与健康教育需求调研基础上初步构建HBV孕产妇核苷类抗病毒治疗健康教育路径的框架与内容,采用目的性抽样方法选取20名工作经验丰富的感染性妇产科医疗、护理专家作为咨询对象,利用德尔菲法确立健康教育路径的最终结构与各项评估指标,并运用专家意见的积极系数、协调程度与权威系数等指标对咨询的可靠性和代表性进行检验。结果两轮专家函询的积极系数均为100%,专家权威程度系数为0.900,专家意见协调系数为0.167;最终确定的健康教育路径包括5个一级指标、28个二级指标、134个三级指标。结论基于德尔菲法构建的健康教育路径完善并规范了核苷类抗病毒治疗HBV孕产妇全程健康教育内容与流程,其指标具有较高的专家认可程度和一致性。
Objective To construct health education path of nucleoside antiviral treatment on pregnant& maternal women with HBV, so as to make the health education with complete content and standard procedure. Methods On the basis of literature review and health education demand investigation and research, framework and content of the health education path was preliminarily constructed of nucleoside antiviral treatment on pregnant & maternal women with HBV. 20 medical and nursing specialists with rich working experience in infectious department of obstetrics and gynecology were selected by purposeful sampling as consulting object. Final structure and the evaluation indexes of the health education path were established by using Delphi method. Reliability and representativeness of the consultation were tested by indexes like active coefficient of expert opinion, coordination degree, authoritative coefficient, etc.Results In the two rounds of expert letter-enquiry, positive coefficient was both 100%, authority degree coefficient of experts was 0. 900, and coordination coefficient of expert opinion was 0. 167. In the finally decided health education path, five first level indexes, 28 secondary indexes and 134 tertiary indicators were included. Conclusions The health education path constructed basing on Delphi method perfected and standardized content and process of the whole health education of nucleoside antiviral treatment on pregnant & maternal women with HBV, with the indexes having high degree of expert approval and consistency.
出处
《中华现代护理杂志》
2016年第22期3130-3133,共4页
Chinese Journal of Modern Nursing
基金
2014南京市医学科技发展资金项目(YKK14155)
关键词
德尔菲法
HBV孕产妇
核苷类抗病毒治疗
健康教育路径
Delphi method
Pregnant &amp
maternal women with HBV
Nucleoside antiviral treatment
Health education path